Skip to main content
SpringerLink
Log in

Assessment of the Risk-Benefit Ratio for Antiarrhythmic Drug Use

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Arrhythmia treatment has always been difficult, particularly as there are no good indicators of the optimal management strategy. The introduction of new antiarrhythmic agents has forced reappraisal of how these drugs are used. Dynamic electrocardiography and invasive electrophysiological studies are important tools for classifying and characterising arrhythmias and for assessing the efficacy of therapy. There is still an enormous gulf between present day treatment and a scientific basis for drug selection, but risk-benefit analysis is possible, at least for patient populations and for some specific arrhythmias. Individual risk-benefit analysis, much needed by clinicians, is still a long way from reality.

This article examines the concept of risk-benefit analysis and indicates those areas where progress can be made.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adams PC, Campbell RWF, Julian DG. The clinical pharmacology of antiarrhythmic drugs. In Conte R (Ed.) Cardiac drug therapy, pp. 153–190, Davis, Philadelphia, 1984

    Google Scholar 

  • Adams PC, Holt DW, Storey GCA, Morley AR, Callaghan J, et al. Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy. Circulation 72: 1064–1075, 1985

    Article  PubMed  CAS  Google Scholar 

  • Adgey AAJ, Allen JD, Geddes JS, James RGG, Webb SW, et al. Acute phase of myocardial infarction. Lancet 2: 501–504, 1971

    Article  PubMed  CAS  Google Scholar 

  • Bigger JT. Identification of patients at high risk for sudden cardiac death. American Journal of Cardiology 54: 3D–38D, 1984

    Article  PubMed  Google Scholar 

  • Bourke JP, Cowan JC, Tansuphaswadikul S, Campbell RWF. Antiarrhythmic drug effects on left ventricular performance. European Heart Journal 8: 105–111, 1987a

    PubMed  Google Scholar 

  • Bourke JP, Tansuphaswadikul S, Cowan JC, Hilton CJ, Campbell RWF. Role of surgical therapy for sustained ventricular tachycardia and fibrillation early after myocardial infarction. In Breithardt et al. (Eds) Non pharmacological therapy of tachyarrhythmias, pp. 93–107, Futura, New York, 1987b

    Google Scholar 

  • Brodsky M, Wu D, Denes P, Kanakis C, Rosen KM. Arrhythmias documented by 24-hour continuous ECG monitoring in 50 male medical students without apparent heart disease. American Journal of Cardiology 39: 390–395, 1977

    Article  PubMed  CAS  Google Scholar 

  • Brown MA, Smith WM, Lubbe WF, Norris RM. Amiodarone induced Torsade de pointes. European Heart Journal 7: 234–239, 1986

    PubMed  CAS  Google Scholar 

  • Brugada P, Abdollah H, Heddle B, Wellens HJJ. Results of a ventricular stimulation protocol using a maximum of 4 premature stimuli in patients without documented or suspected ventricular arrhythmias. American Journal of Cardiology 52: 1214–1218, 1983

    Article  PubMed  CAS  Google Scholar 

  • Brugada P, Wellens HJJ. Programmed electrical stimulation of the heart to select antiarrhythmic drug treatment in patients with recurrent ventricular arrhythmias. European Heart Journal 8: 91–95, 1987

    Google Scholar 

  • Campbell RWF. Ventricular ectopic activity and its relevance to aircrew licencing. European Heart Journal 5: 95–98, 1984

    PubMed  Google Scholar 

  • Campbell RWF. Newer antiarrhythmic drugs. In Kulbertus HE (Ed.) Medical management of cardiac arrhythmias, pp. 55–69, Churchill Livingstone, Edinburgh, 1986

    Google Scholar 

  • Campbell RWF. Arrhythmogenesis: a European perspective. American Journal of Cardiology 59: 49E–51E, 1987

    Article  PubMed  CAS  Google Scholar 

  • Campbell RWF, Cowan JC. Human electrophysiology: mechanisms of arrhythmia prevention and the action of amiodarone. British Journal of Clinical Practice 44: 99–103, 1986

    PubMed  CAS  Google Scholar 

  • Campbell RWF, Godman MJ, Fiddler GI, Marquis RMM, Julian DG. Ventricular arrhythmias in syndrome of balloon deformity of mitral valve: definition of possible high risk group. British Heart Journal 38: 1053–1057, 1976

    Article  PubMed  CAS  Google Scholar 

  • Campbell RWF, Murray A, Julian DG. Ventricular arrhythmias in first 12 hours of acute myocardial infarction: natural history study. British Heart Journal 46: 351–357, 1981

    Article  PubMed  CAS  Google Scholar 

  • Campbell RWF, Smith RA, Gallagher JJ, Pritchett ELC, Wallace AG. Atrial fibrillation in the pre-excitation syndrome. American Journal of Cardiology 40: 514–520, 1977

    Article  PubMed  CAS  Google Scholar 

  • CAPS Investigators. The Cardiac Arrhythmia Pilot Study. American Journal of Cardiology 57: 91–95, 1986

    Article  Google Scholar 

  • Chakko S, Ghecrghiade M. Ventricular arrhythmias in severe heart failure: incidence, significance and effectiveness of therapy. American Heart Journal 109: 497–504, 1985

    Article  PubMed  CAS  Google Scholar 

  • Chizner MA, Pearle DL, de Leon AC. The natural history of aortic stenosis in adults. American Heart Journal 99: 419–424, 1980

    Article  PubMed  CAS  Google Scholar 

  • Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harsten WE, et al. Veterans Administration Co-operative Study: effect of vasodilator therapy on mortality in chronic congestive heart failure. New England Journal of Medicine 314: 1547–1552, 1986

    Article  PubMed  CAS  Google Scholar 

  • CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. New England Journal of Medicine 316: 1429–1435, 1987

    Article  Google Scholar 

  • Coumel P, Leclerq JF, Escoubet B. Beta-blockers: use for arrhythmias. European Heart Journal 8: 41–52, 1987

    PubMed  Google Scholar 

  • Cowan JC, Bourke J, Campbell RWF. Arrhythmogenic effects of antiarrhythmic drugs. European Heart Journal 8: 133–136, 1987

    PubMed  Google Scholar 

  • Cullen K, Stenhouse NS, Wearne KL, Cumpston GN. Electrocardiographic and 13 year cardiovascular mortality in Bussleton study. British Heart Journal 47: 209–212, 1982

    Article  PubMed  CAS  Google Scholar 

  • Denes P, Gabster A, Huang SK. Clinical electrocardiographic and follow-up observations in patients having ventricular fibrillation during Holier monitoring: role of quinidine therapy. American Journal of Cardiology 48: 9–16, 1981

    Article  PubMed  CAS  Google Scholar 

  • Dessertenne F. La tachycardia ventriculaire à deux foyers opposés variables. Archives des Maladies du Coeur et des Vaisseaux 59: 263–272, 1966

    PubMed  CAS  Google Scholar 

  • DiMarco JP, Lerman BB, Kron IL, Sellers TD. Sustained ventricular tachyarrhythmias within two months of acute myocardial infarction; results of medical and surgical therapy in patients resuscitated from the initial episode. Journal of the American College of Cardiology 6: 759–768, 1985

    Article  PubMed  CAS  Google Scholar 

  • Falk RH, Knowlton AA, Bernard SA, Gotlieb NE, Battinelli NJ. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm: a randomised, double blinded trial. Annals of Internal Medicine 106: 503–506, 1987

    PubMed  CAS  Google Scholar 

  • Gabry MD, Brodman R, Johnston D, et al. Automatic implantable cardioverter-defibrillation: patient survival, battery longevity and shock delivery analysis. Journal of the American College of Cardiology 9: 1349–1356, 1987

    Article  PubMed  CAS  Google Scholar 

  • Gallagher JJ, Pritchett ELC, Sealy WC, Kasell J, Wallace AG. The pre-excitation syndromes. Progress in Cardiovascular Diseases 20: 285–327, 1978

    Article  PubMed  CAS  Google Scholar 

  • Gertz MA, Garton JP, Jennings WH. Aplastic anemia due to tocainide. New England Journal of Medicine 314: 583–634, 1986

    Article  PubMed  CAS  Google Scholar 

  • Gimeno G, Winkle RA. The normal DCG. In Campbell & Murray (Eds) Dynamic electrocardiography, pp. 37–46, Churchill Livingstone, Edinburgh, 1985

    Google Scholar 

  • Gottlieb SH, Achuff SC, Mellits ED, et al. Prophylactic antiarrhythmic therapy of high risk survivors of myocardial infarction: lower mortality at 1 month but not at 1 year. Circulation 75: 792–799, 1987

    Article  PubMed  CAS  Google Scholar 

  • Hauer RNW, Lie KI, Liem KL, Durrer D. Long term prognosis in patients with bundle branch block complicating acute anteroseptal infarction. American Journal of Cardiology 449: 1581–1585, 1982

    Article  Google Scholar 

  • Hinton RC, Kistler JP, Fallon JT, Friedlich AL, Fisher CM. Influence of aetiology of atrial fibrillation on incidence of systemic embolism. American Journal of Cardiology 40: 509–513, 1977

    Article  PubMed  CAS  Google Scholar 

  • Horowitz LN, Josephson ME, Koster JA. Intracardiac electro-physiology study as a method of optimisation of drug therapy in chronic VT. Progress in Cardiovascular Diseases 2: 81–98, 1980

    Article  Google Scholar 

  • Jervell A, Lange-Neilsen F. Congenital deaf mutism functional heart disease with prolongation of the QT interval and sudden death. American Heart Journal 54: 59–60, 1947

    Article  Google Scholar 

  • Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, et al. Long term follow up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. New England Journal of Medicine 312: 193–197, 1985

    Article  PubMed  CAS  Google Scholar 

  • Kennelly BA. Comparison of lidoflazine and quinidine in prophylactic treatment of arrhythmias. British Heart Journal 39: 540–546, 1977

    Article  PubMed  CAS  Google Scholar 

  • Kontopoulos A, Filindris A, Manoudis F, Metaxas P. Sotalol induced Torsades de pointes. Postgraduate Medical Journal 47: 321–323, 1981

    Article  Google Scholar 

  • Koster RW, Dunning AJ. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalisation phase of acute myocardial infarction. New England Journal of Medicine 313: 1105–1110, 1985

    Article  PubMed  CAS  Google Scholar 

  • Krikler DM, Curry PVL. Torsade de pointes, an atypical ventricular tachycardia. British Heart Journal 38: 117–120, 1976

    Article  PubMed  CAS  Google Scholar 

  • Lie KI, Liem KL, Louridtz WL, Janse MJ, Willebrands AF, et al. Efficacy of lignocaine in preventing ventricular fibrillation within 1 hour after a 300 ms intramuscular injection: a double blind randomised study of 300 hospitalised patients with acute myocardial infarction. American Journal of Cardiology 42: 486–488, 1978a

    Article  PubMed  CAS  Google Scholar 

  • Lie KI, Liem KL, Schuilenberg RM, David GK, Durrer D. Early identification of patients developing late in-hospital ventricular fibrillation after discharge from the coronary care unit: a 5.5 year retrospective study of 1897 patients. American Journal of Cardiology 41: 674–677, 1978b

    Article  PubMed  CAS  Google Scholar 

  • Lie KI, Wellens HJJ, Von Capelle FJ, Durrer D. Lidocaine in the prevention of primary ventricular fibrillation. New England Journal of Medicine 29: 1324–1326, 1974

    Article  Google Scholar 

  • Marchlinski FE, Buxton AE, Miller JM, Vassallo JA, Flores BT, et al. Amiodarone versus amiodarone and a type 1A agent for treatment of patients with rapid ventricular tachycardia. Circulation 74: 1037–1043, 1986

    Article  PubMed  CAS  Google Scholar 

  • Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. American Journal of Cardiology 48: 252–257, 1981

    Article  PubMed  CAS  Google Scholar 

  • May GS, Eberlein KA, Fubers CD, Passamani ER, DeMets DL. Secondary prevention after myocardial infarction: a review of long term trials. Progress in Cardiovascular Diseases 24: 331–352, 1982

    Article  PubMed  CAS  Google Scholar 

  • McGovern B, Garan H, Kelly E, Ruskin JN. Adverse reactions during treatment with amiodarone hydrochloride. British Medical Journal 287: 175–180, 1983

    Article  PubMed  CAS  Google Scholar 

  • McKenna WJ, England D, Doi YL, Deanfield JE, Oakley CM, et al. Arrhythmia in hypertrophic cardiomyopathy: influence on prognosis. British Heart Journal 46: 168–172, 1981a

    Article  PubMed  CAS  Google Scholar 

  • McKenna WJ, Harris L, Perez G, Krikler DM, Oakley C, et al. Arrhythmias in hypertrophic cardiomyopathy. II. Comparison of amiodarone and verapamil in treatment. British Heart Journal 46: 173–178, 1981b

    Article  PubMed  CAS  Google Scholar 

  • Michelson EL, Morganroth J. Spontaneous variability of complex ventricular arrhythmias detected by long-term electrocardiographic recording. Circulation 61: 690–695, 1980

    Article  PubMed  CAS  Google Scholar 

  • Mogensen L. A controlled trial of lignocaine prophylaxis in the prevention of ventricular tachyarrhythmias in acute myocardial infarction. Acta Medica Scandinavica 513: 1–80, 1971

    Google Scholar 

  • Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. New England Journal of Medicine 309: 331–336, 1983

    Article  Google Scholar 

  • Nathan AW, Hellestrand KJ, Bexton RS, Banim SO, Spurrell RAJ, et al. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate. American Heart Journal 107: 222–228, 1984

    Article  PubMed  CAS  Google Scholar 

  • Olsson G, Rehnqvist N. Evaluation of antiarrhythmic effects of metoprolol treatment after acute myocardial infarction: relationship between treatment responses and survival during a 3 year follow up. European Heart Journal 7: 312–319, 1986

    PubMed  CAS  Google Scholar 

  • Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation 72: 681–685, 1985

    Article  PubMed  CAS  Google Scholar 

  • Rasmussen K, Lunde PI, Lie M. Coronary bypass surgery in exercise induced ventricular tachycardia. European Heart Journal 8: 444–448, 1987

    PubMed  CAS  Google Scholar 

  • Roth A, Harrison E, Mitani G, Cohen J, Rahimtoola SH, et al. Efficacy and safety of medium and high dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation. Circulation 73: 316–324, 1986

    Article  PubMed  CAS  Google Scholar 

  • Sami M, Kraemer H, Harrison DC, Houston N, Shimasaki C, et al. A new method for evaluating antiarrhythmic drug efficacy. Circulation 62: 1172–1179, 1980

    Article  PubMed  CAS  Google Scholar 

  • Scheinman BD, Evans T. Acceleration of ventricular rate by fibrillation associated with the Wolff Parkinson White syndrome. British Medical Journal 285: 999–1000, 1982

    Article  Google Scholar 

  • Schwartz PJ. The idiopathic long QT syndrome: the need for a prospective registry. European Heart Journal 4: 529–531, 1983

    PubMed  CAS  Google Scholar 

  • Shaw DB, Kekwick CA, Veake D, Gowers J, Whistance T. Survival in second degree atrioventricular block. British Heart Journal 53: 587–593, 1985

    Article  PubMed  CAS  Google Scholar 

  • Snow PJD. Effect of propranolol in myocardial infarction. Lancet 2: 551–553, 1965

    Article  PubMed  CAS  Google Scholar 

  • Soff GA, Kadin ME. Tocainide induced reversible agranulocytosis and anemia. Archives of Internal Medicine 147: 598–599, 1987

    Article  PubMed  CAS  Google Scholar 

  • Stoel I, Hagemeijer F. Aprindine: a review. European Heart Journal 1: 147–156, 1980

    PubMed  CAS  Google Scholar 

  • Torres V, Rowers D, Somberg JC. The arrhythmogenicity of antiarrhythmic drugs. American Heart Journal 109: 1090–1097, 1985

    Article  PubMed  CAS  Google Scholar 

  • Tzivoni D, Keren A, Cohen AM, Loebel H, Zahavi I, et al. Magnesium therapy for torsades de Pointes. American Journal of Cardiology 53: 528–530, 1984

    Article  PubMed  CAS  Google Scholar 

  • Volosin K, Greenberg RM, Greenspan AJ. Tocainide associated agranulocytosis. American Heart Journal 109: 1392–1393, 1985

    Article  PubMed  CAS  Google Scholar 

  • Ward DE, Camm AJ, Spurrell RAJ. Patients with resistant paroxysmal tachycardias. British Heart Journal 44: 91–95, 1980

    Article  PubMed  CAS  Google Scholar 

  • Winkle RA, Mason JW, Griffin JC, Ross D. Malignant ventricular tachyarrhythmias associated with the use of encainide. American Heart Journal 102: 854–864, 1981

    Google Scholar 

  • Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomised trial. Progress in Cardiovascular Diseases 27: 335–371, 1985

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Freeman Hospital, Newcastle upon Tyne, NE7 7DN, England

    R. W. F. Campbell (British Heart Foundation Professor of Cardiology)

Authors
  1. R. W. F. Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Campbell, R.W.F. Assessment of the Risk-Benefit Ratio for Antiarrhythmic Drug Use. Drugs 36, 616–632 (1988). https://doi.org/10.2165/00003495-198836050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198836050-00005

Keywords

Search

Navigation